A Study to Compare PK, PD and Safety of UI058 and UIC202004 in Healthy Subjects

NCT05282914 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

GERD

Interventions

DRUG: administration of UI058
DRUG: administration of UIC202004

Sponsor

Korea United Pharm. Inc.